High doses of ascorbic acid may interfere with urinary glucose determinations using the glucose oxidase method
The type I form represents about 20% of all CGD cases and is caused by mutations in the neutrophil cytosolic factor 1 (NCF1) gene, which encodes the p47-PHOX protein
Its classified as a performance-enhancing substance, so it could have implications if youre in competitive athletics
Scientific References: Dou Y, Lee A, Zhu L, Morton J, Ladiges W., Aging Pathobiology and Therapeutics , 2020
Gota V, Goda JS, Doshi K et al (2016) Biodistribution and pharmacokinetic study of 3,3 diselenodipropionic acid (DSePA), a synthetic radioprotector, in mice